EPICOMBI.AI
EpiCombi.AI is a genomics signature-driven therapeutics spinout from Oxford University, is overcoming epigenetic barriers in cancer complexity through the creation of AI-derived, network-acting multi-targeted drugs.
EPICOMBI.AI
Industry:
Artificial Intelligence Biotechnology Machine Learning
Founded:
2017-01-01
Address:
Oxford, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.epicombi.ai
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Font Awesome Mobile Non Scaleable Content Amazon JsDelivr
Similar Organizations
Cambrium
Cambrium is engineering biology to create high-performance proteins.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Oseven Telematics
Insurance telematics and driving behavioural analytics
Current Employees Featured
Founder
Investors List
Illumina Accelerator
Illumina Accelerator investment in Seed Round - EpiCombi.AI
